ConductScience.org, home

Paper36095053

The role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2.

Shirotani K and 4 others. J Biochem, 2022. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. The role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2. Papers, record 36095053. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36095053

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2.
PubMed
Journal
J Biochem
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2022-12-06
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shirotani KKeiro
2Hatta DDaisuke
3Wakita NNaoki
4Watanabe KKaori
5Iwata NNobuhisa

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Neurodegenerative DiseasesMajor topic
Humans
Microglia
Signal Transduction
Polysaccharides
Membrane Glycoproteins
Receptors, Immunologic

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42728596Post-translational modifications in Neuroimmune cells during neuroinflammation: integrated regulatory networks and therapeutic opportunities.Biol Direct2026https://conductscience.org/library/papers/42728596PubMed
42714953TREM2: A Potential Target for the Targeted Therapy of Metabolic Diseases.Mediators Inflamm2026https://conductscience.org/library/papers/42714953PubMed
42288287Uncovering the biological mechanisms of TREM2 with molecular simulations: A comprehensive review and perspective.Prog Biophys Mol Biol2026https://conductscience.org/library/papers/42288287PubMed
41998699Triggering receptor expressed on myeloid cell family in atherosclerosis: from mechanisms to intervention strategies.Cell Commun Signal2026https://conductscience.org/library/papers/41998699PubMed
41980098Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41980098PubMed
41708000Sialylation in the nervous system: Functions and mechanisms.J Biol Chem2026https://conductscience.org/library/papers/41708000PubMed
41509917Obesity-induced pyroptotic adipocyte death leads to TREM2-dependent macrophage dysfunction and adipose tissue inflammation.iScience2026https://conductscience.org/library/papers/41509917PubMed
41462898Unlocking the Sugar Code: Implications and Consequences of Glycosylation in Alzheimer's Disease and Other Tauopathies.Biomedicines2025https://conductscience.org/library/papers/41462898PubMed
41168805Roles of TREM2 in Alzheimer's disease.Transl Neurodegener2025https://conductscience.org/library/papers/41168805PubMed
41087652The emerging landscape of brain glycosylation: from molecular complexity to therapeutic potential.Exp Mol Med2025https://conductscience.org/library/papers/41087652PubMed
40928206The flexible stalk domain of sTREM2 modulates its interactions with brain-based phospholipids.Elife2025https://conductscience.org/library/papers/40928206PubMed
40069587Deciphering distinct spatial alterations in N-glycan expression profiles in the spinal cord and brain of male rats in a neuropathic pain model.Cell Mol Biol Lett2025https://conductscience.org/library/papers/40069587PubMed
39817909Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation.Cell Rep2025https://conductscience.org/library/papers/39817909PubMed
37986179Alzheimer's genes in microglia: a risk worth investigating.Mol Neurodegener2023https://conductscience.org/library/papers/37986179PubMed
37626031New insight into protein glycosylation in the development of Alzheimer's disease.Cell Death Discov2023https://conductscience.org/library/papers/37626031PubMed
37235776Total Chemical Synthesis of Glycosylated TREM2 Ectodomain.ACS Chem Neurosci2023https://conductscience.org/library/papers/37235776PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TREM254209PubTator's text mininghttps://conductscience.org/library/genes/54209

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36095053

GET https://conductscience.org/api/papers/v1/36095053/authors